ARCHIVES

Bertagnolli: Why Brigham Stopped Making Morcellation Available Outside Of A Registry Trial

This article is from The Cancer Letter archive.

Vol. 40 No. 27 | July 4, 2014

Download PDF Visit The Full Archive

Related Articles

Senate Confirms McClellan For FDA

October 25, 2002

De-Emphasis of Tradition Grants Still Haunts Some; “Recent NCI Actions Held Up As Evidence

May 21, 1976

FDA Approves Inlyta Pill For Renal Cell Carcinoma

January 27, 2012

In Brief: D. Gary Gilliland Named President and Director of Fred Hutchinson Cancer Research Center

November 21, 2014

Cancer Facts & Figures: Cancer Mortality Down 20 Percent Since 1991

January 25, 2013

Spending Freeze Could Harm Medical Research, ACS Advocacy Affiliate Says

January 29, 2010